Director/PDMR Shareholding

Arix Bioscience PLC (ARIX) Director/PDMR Shareholding 16-Aug-2021 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Arix Bioscience plc Director/PDMR Shareholding Arix Bioscience plc (the "Company") today announces the annual award of nil cost options to Interim CEO Robert Lyne, which are subject to performance conditions over a three-year assessment period, in accordance with the Company's Remuneration Policy. PDMR DEALING NOTIFICATION Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 1 Details of the person discharging managerial responsibilities / person closely associated a) Name Robert Lyne 2 Reason for the notification a) Position / status Interim Chief Executive Officer b) Initial notification / Amendment Initial Notification 3 Details of issuer a) Name Arix Bioscience plc b) LEI 213800OVT3AHQCXNIX43 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of instrument Ordinary Shares of Arix Bioscience plc Identification code GB00BD045071 b) Nature of the transaction Award of nil-cost options under the Arix Bioscience plc Executive Incentive Plan ("EIP")  c) Price(s) and volume(s) Price(s) Volume(s) Nil 352,335 d) Aggregated information Aggregated price Aggregated volume N/A (single transaction) N/A (single transaction) e) Date of the transaction 13 August 2021 f) Place of the transaction Outside a trading venue   For further information please contact: Optimum Strategic Communications Mary Clark, Manel Mateus [phone] [e-mail]   - Ends -

ISIN:	GB00BD045071
Category Code:	DSH
TIDM:	ARIX
LEI Code:	213800OVT3AHQCXNIX43
OAM Categories:	2.3. Major shareholding notifications
Sequence No.:	119950
EQS News ID:	1226354

End of Announcement	EQS News Service